VAREX IMAGING CORP (VREX) — insider trading
Health Care · NASDAQ
VAREX IMAGING CORP (VREX) has 22 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 22 (latest 2026-10-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Martinez Matthew Aaron | Officer (Chief Legal Officer) | Grant / award / vesting (derivative) | 5,411 | — | $0 | Form 4 |
| 2026-10-12 | Martinez Matthew Aaron | Officer (Chief Legal Officer) | Grant / award / vesting (derivative) | 5,411 | — | $0 | Form 4 |
| 2026-09-14 | Kunkel Jay K. | Director | Open-market sale | 8,121 | $18.48 | $150.1K | Form 4 |
| 2026-09-11 | Maheshwari Shubham | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 160,944 | — | $0 | Form 4 |
| 2026-09-11 | Maheshwari Shubham | Officer (Chief Financial Officer) | Open-market sale | 130,000 | $18.46 | $2.40M | Form 4 |
| 2026-09-11 | Maheshwari Shubham | Officer (Chief Financial Officer) | Option exercise / conversion | 160,944 | $13.61 | $2.19M | Form 4 |
| 2026-08-14 | Aranki Karen L | Officer (Chief Human Resources Officer) | Option exercise / conversion (derivative) | 3,974 | — | $0 | Form 4 |
| 2026-08-14 | Aranki Karen L | Officer (Chief Human Resources Officer) | Shares withheld for taxes / exercise cost | 1,145 | $18.49 | $21.2K | Form 4 |
| 2026-08-14 | Aranki Karen L | Officer (Chief Human Resources Officer) | Option exercise / conversion | 3,974 | — | — | Form 4 |
| 2026-03-20 | Kunkel Jay K. | Director | Open-market sale | 4,510 | $11.14 | $50.2K | Form 4 |
| 2026-02-12 | Chertoff Jocelyn D | Director | Grant / award / vesting (derivative) | 12,331 | — | $0 | Form 4 |
| 2026-02-12 | GUERTIN TIMOTHY E | Director | Grant / award / vesting (derivative) | 12,331 | — | $0 | Form 4 |
| 2026-02-12 | TSINGOS CHRISTINE A | Director | Grant / award / vesting (derivative) | 12,331 | — | $0 | Form 4 |
| 2026-02-12 | Rosebrough Walter M Jr | Director | Grant / award / vesting (derivative) | 14,947 | — | $0 | Form 4 |
| 2026-02-12 | Kunkel Jay K. | Director | Grant / award / vesting (derivative) | 12,331 | — | $0 | Form 4 |
| 2026-02-12 | Bardwell Kathleen | Director | Grant / award / vesting (derivative) | 12,331 | — | $0 | Form 4 |
| 2026-02-09 | Kunkel Jay K. | Director | Option exercise / conversion (derivative) | 8,483 | — | $0 | Form 4 |
| 2026-02-09 | Kunkel Jay K. | Director | Option exercise / conversion | 8,483 | — | — | Form 4 |
| 2026-02-09 | Rosebrough Walter M Jr | Director | Option exercise / conversion (derivative) | 10,339 | — | $0 | Form 4 |
| 2026-02-09 | Rosebrough Walter M Jr | Director | Option exercise / conversion | 10,339 | — | — | Form 4 |
| 2026-02-09 | Chertoff Jocelyn D | Director | Option exercise / conversion (derivative) | 8,483 | — | $0 | Form 4 |
| 2026-02-09 | Chertoff Jocelyn D | Director | Option exercise / conversion | 8,483 | — | — | Form 4 |
Ask the chat about VREX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: VAREX IMAGING CORP (VREX).
Last updated 2026-10-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.